Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)
Menter, A., Warren, R.B., Langley, R.G., Merola, J.F., Kerr, L.N., Dennehy, E.B., Shrom, D., Amato, D., Okubo, Y., Reich, K.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Get full text
Journal Article
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis
Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.06.2017)
Get full text
Journal Article
Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis
Zhu, B., Edson-Heredia, E., Cameron, G.S., Shen, W., Erickson, J., Shrom, D., Wang, P., Banerjee, S., Gordon, K.B.
Published in British journal of dermatology (1951) (01.12.2013)
Published in British journal of dermatology (1951) (01.12.2013)
Get full text
Journal Article
Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial
Rosmarin, D., Smith, S., Shrom, D., Burge, R., See, K., McKean‐Matthews, M., Ridenour, T., Lin, C.‐Y., Gorelick, J.
Published in Skin health and disease (01.09.2021)
Published in Skin health and disease (01.09.2021)
Get full text
Journal Article
540 Rapid response in PASI, sPGA, and BSA measures for patients with moderate-to-severe plaque psoriasis with ixekizumab
Leonardi, C., Burge, R., See, K., Shrom, D., Guo, J., McKean-Matthews, M., Amato, D., Gallo, G., Gooderham, M.
Published in Journal of investigative dermatology (01.05.2019)
Published in Journal of investigative dermatology (01.05.2019)
Get full text
Journal Article
713 The association between disease severity at time of retreatment and probability of recapture in psoriasis patients receiving ixekizumab
Leonardi, C., Mroweitz, U., See, K., Shrom, D., McKean-Matthews, M., Gallo, G., Nickoloff, B.J., Wu, J.
Published in Journal of investigative dermatology (01.05.2019)
Published in Journal of investigative dermatology (01.05.2019)
Get full text
Journal Article
Deficient Neurogenesis in Forebrain-Specific Presenilin-1 Knockout Mice Is Associated with Reduced Clearance of Hippocampal Memory Traces
Feng, Ruiben, Rampon, Claire, Tang, Ya-Ping, Shrom, David, Jin, Janice, Kyin, Maureen, Sopher, Bryce, Martin, George M, Kim, Seong-Hun, Langdon, Ronald B, Sisodia, Sangram S, Tsien, Joe Z
Published in Neuron (Cambridge, Mass.) (06.12.2001)
Published in Neuron (Cambridge, Mass.) (06.12.2001)
Get full text
Journal Article
Forebrain Degeneration and Ventricle Enlargement Caused by Double Knockout of Alzheimer's presenilin-1 and presenilin-2
Feng, Ruiben, Wang, Huimin, Wang, Jianlin, Shrom, David, Zeng, Xuemei, Tsien, Joe Z., Rosenberg, Leon E.
Published in Proceedings of the National Academy of Sciences - PNAS (25.05.2004)
Published in Proceedings of the National Academy of Sciences - PNAS (25.05.2004)
Get full text
Journal Article
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience
Callis Duffin, Kristina, Bukhalo, Michael, Bobonich, Margaret A, Shrom, David, Zhao, Fangyi, Kershner, James R, Gill, Anne, Pangallo, Beth, Shuler, Catherine L, Bagel, Jerry
Published in Medical devices (Auckland, N.Z.) (01.01.2016)
Published in Medical devices (Auckland, N.Z.) (01.01.2016)
Get full text
Journal Article
Rapidité d’action de l’ixékizumab : analyse groupée de 2 essais randomisés de phase 3 (UNCOVER-2 et 3) chez des patients atteints de psoriasis
Leonardi, C., Langley, R., Blauvelt, A., Gordon, K., Shrom, D.-S., Farmer Kerr, L.-N., Stoykov, I., Ojeh, C., Reich, K., Augendre-Ferrante, B.
Published in Annales de dermatologie et de vénéréologie (01.12.2016)
Published in Annales de dermatologie et de vénéréologie (01.12.2016)
Get full text
Journal Article
Ixekizumab dans le traitement du psoriasis en plaques modéré à sévère : résultats à 60 semaines d’une étude de phase 3, en double aveugle, avec une phase d’induction suivie d’une phase de re-randomisation (UNCOVER-1)
Gordon, K., Blauvelt, A., Langley, R., Luger, T., Ohtsuki, M., Cameron, G., Braun, D., Erickson, J., Zhao, F., Shrom, D., Osuntokun, O., Heffernan, M., Nickoloff, B., Leonardi, C., Augendre-Ferrante, B.
Published in Annales de dermatologie et de vénéréologie (01.12.2015)
Published in Annales de dermatologie et de vénéréologie (01.12.2015)
Get full text
Journal Article